One dividend stock picking up steam of late that investors should consider buying is Viatris (NASDAQ: VTRS) . The healthcare company recently reported earnings that were incredibly positive. Shares have been on the rise -- up 13% in just the past month, right along with the S&P 500 .
But there could be more gains to come for Viatris as the stock remains cheap. Let's see why.
Viatris is a global pharmaceutical company that makes and sells branded, generic, and biosimilar drugs. Its products span broad therapeutic areas, including oncology, immunology, diabetes, cardiovascular, and infections disease. Its top product, Lipitor, treats high cholesterol and generated $846 million of sales in the first half of this year.
For further details see:
This Beaten-Down Dividend Stock Is a Scorching-Hot Buy